Currently, nanoparticle albumin-bound paclitaxel (nab-paclitaxel) combined with cisplatin is a recommended treatment regimen for recurrent or metastatic NPC, but studies on the treatment of LA-NPC are limited. This evidence concerns the gene ALB and nasopharyngeal carcinoma.